ARCHIVES

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

This article is from The Cancer Letter archive.

Vol. 01 No. 25 | June 20, 1975

Download PDF Visit The Full Archive

Related Articles

Waksal To Pay Back $800,000 In Profits From Stock Sales

March 14, 2003

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990

Administration Seeks Authorization Bill Repealing National Cancer Act, Other NIH Special Authorities

March 8, 1985

FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says.

January 14, 2005

FY 1984 Bypass Budget Shown By Mechanism,, Research Program

July 2, 1982

Local University Competing for Part FCRF Contract

December 4, 1981